Karen Preble

Karen Preble has a diverse work experience spanning multiple companies in the pharmaceutical industry. Karen started their career at Pfizer in 2002, where they served as the Director of Global Respiratory and Analgesic Marketing until 2005. Karen then moved to Sanofi, where they held various roles including Director of Cardiovascular New Products, Director of CV Marketing and Patient Advocacy, Cardiovascular Marketing, and Sr. Director of Marketing/Market Development for Soliqua. In 2017, Karen joined Intarcia Therapeutics, Inc. as the Senior Director of ITCA 650. Karen subsequently joined Intercept Pharmaceuticals in 2018 as the Global Strategic Marketing-NASH, and later became the Executive Director of Global Corporate Communications and Patient Advocacy.

Karen Preble has a Bachelor of Science degree from the University of Florida in the College of Journalism and Communications. Karen also holds a Master of Business Administration degree from the University of Florida's Warrington College of Business. The exact years of their education were not provided.